Follow
CAR-T biomarker discovery
Chimeric antigen receptor (CAR) T cell therapy is an emerging form of immunotherapy which engineers a patient's immune cells to better identify and kill cancer cells. While CAR-T cell therapy can cure hard-to-treat cancers, only a small proportion of patients respond favorably. Identifying biomarkers, biological molecules that be predict how a person may respond to a treatment, can help doctors determine which patients will benefit from this therapy. Because CAR-T cell therapy is costly and time-consuming, there is an effort to promote research focused on discovering biomarkers to manage treatment.
What's Popular in CAR-T biomarker discovery
-
NOV 08, 2023Cancer
Adoptive cell therapy has emerged as a promising alternative treatment for hematological and solid cancers, with CAR-T t ...Sponsored By: Sino BiologicalOCT 17, 2023Cancer
Introduction CAR-T therapies represent a new successful strategy for the treatment of hematological malignancies; howeve ...Sponsored By: Sino BiologicalMAY 31, 2021Immunology
Cell therapies use engineered T cells extracted from the patient’s own immune system to rally an attack on tumors. ...Written By: Tara FernandesAPR 13, 2020Cancer
In the past, the go-to drugs have always been small molecules. These small molecules would interact with the cell and ac ...Written By: Jasper Cantrell
NOV 08, 2023
Cancer
Adoptive cell therapy has emerged as a promising alternative treatment for hematological and solid cancers, with CAR-T t
...
Sponsored By:
Sino Biological
OCT 17, 2023
Cancer
Introduction CAR-T therapies represent a new successful strategy for the treatment of hematological malignancies; howeve
...
Sponsored By:
Sino Biological
MAY 31, 2021
Immunology
Cell therapies use engineered T cells extracted from the patient’s own immune system to rally an attack on tumors.
...
Written By:
Tara Fernandes
APR 13, 2020
Cancer
In the past, the go-to drugs have always been small molecules. These small molecules would interact with the cell and ac
...
Written By:
Jasper Cantrell
JAN 23, 2019
Cardiology
A host of new discoveries bring medicine closer to the goal of ending heart attacks. These include new protective method
...
Written By:
Abbie Arce
AUG 28, 2018
Cell & Molecular Biology
Neutrophils are a highly abundant type of immune cell, outnumbering every other kind that runs through the bloodstream.
Written By:
Carmen Leitch
-
FEB 15, 2023 | 7:00 AM
Date: February 15, 2023 Time: 7:00am (PST), 10:00pm (EST), 4:00pm (CET) While not all microscopy samples can fluoresce, all can scatter light, and this scattered light can be imaged. This ha...Speaker: Philipp Kukura , Francesco Reina , Matthew Kose-Dunn , Phil AllenSponsored By: Teledyne PhotometricsMAY 31, 2022 | 9:00 AM
Date: May 31, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) Introducing Nanostring’s latest spatial platform, CosMx Spatial Molecular Imager (SMI). Offering high-plex, multiomi...APR 21, 2022 | 5:30 AM
A hypoxic tumour microenvironment is a feature of solid tumours. Many tumour types contain high fractions of hypoxic tissue. The relationship between high levels of tumour hypoxia and a poor...
NOV 16, 2021 | 8:00 AM
Date: November 16, 2021 Time: 8:00am (PDT), 11:00am (EDT) The unique suppressive function of regulatory T cells (Treg cells) makes them an interesting target cell population to study. In rec...
NOV 04, 2021 | 8:00 AM
Date: November 4, 2021 Time: 8:00am (PDT), 11:00am (EDT) The promise of tissue clearing techniques in combination with 3D-immunofluorescence (IF) microscopy is revolutionary. Complex biologi...
FEB 15, 2023 | 7:00 AM
Date: February 15, 2023 Time: 7:00am (PST), 10:00pm (EST), 4:00pm (CET) While not all microscopy samples can fluoresce, all can scatter light, and this scattered light can be imaged. This ha...
Speaker:
Philipp Kukura
, Francesco Reina
, Matthew Kose-Dunn
, Phil Allen
Sponsored By: Teledyne Photometrics
MAY 31, 2022 | 9:00 AM
Date: May 31, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) Introducing Nanostring’s latest spatial platform, CosMx Spatial Molecular Imager (SMI). Offering high-plex, multiomi...
APR 21, 2022 | 5:30 AM
A hypoxic tumour microenvironment is a feature of solid tumours. Many tumour types contain high fractions of hypoxic tissue. The relationship between high levels of tumour hypoxia and a poor...
NOV 16, 2021 | 8:00 AM
Date: November 16, 2021 Time: 8:00am (PDT), 11:00am (EDT) The unique suppressive function of regulatory T cells (Treg cells) makes them an interesting target cell population to study. In rec...
NOV 04, 2021 | 8:00 AM
Date: November 4, 2021 Time: 8:00am (PDT), 11:00am (EDT) The promise of tissue clearing techniques in combination with 3D-immunofluorescence (IF) microscopy is revolutionary. Complex biologi...
NOV 03, 2021 | 7:00 AM
Date: November 3, 2021 Time: 7:00am (PDT), 10:00am (EDT) The reconstitution of a fully functional human immune system in mouse after engraftment of purified hCD34+ hematopoietic cells provid...
OCT 07, 2021 | 11:55 PM
Summary: Cancer neoantigens are highly specific to the tumor, potently immunogenic and can be targeted by both vaccines and engineered cellular therapies. This talk will introduce the defini...
OCT 06, 2021 | 12:00 PM
Advancements in immuno-oncology have been moving at an ever-quickening pace. From the development of new CAR-T therapies to a better understanding of the mechanism of action of monoclonal an...
Speaker:
Katie Gillis
, Brian E. Hall
, Stephanie Brunelle, Ph.D.
Presented at: Cancer Research & Oncology Week Virtual Event Series 2021
Sponsored By: Luminex - A DiaSorin Company
Sponsored By: Luminex - A DiaSorin Company
JUL 22, 2021 | 5:00 PM
Though tumor targeting using chimeric receptors (CAR) engineered to bind tumor-associated surface proteins such as CD19 in B cells have demonstrated remarkable efficacy in cancer, this thera...
-
OCT 19, 2022 | 5:30 AM PDT
Labroots announces the 2022 Coronavirus Virtual Event Series. A novel coronavirus emerged in China in 2019; it has since been dubbed COVID-19....OCT 04, 2022 | 5:30 AM PDT
Labroots to host the 10th Annual Event in the Cancer Research & Immuno-Oncology Week Virtual Event Series! This two day event will take place on October 4-6, 2022....APR 19, 2022 | 5:30 AM PDTC.E. CREDITS
Labroots announces our 10th Annual Event in the Genetics Week Virtual Event Series on April 19-21, 2022! Genetics Week Virtual Event Series 2022 will offer a multi-day content-rich program....FEB 23, 2022 | 5:30 AM PST
Labroots and the Drug Discovery planning committee are pleased to announce its 5th annual event in the Drug Discovery & Development Virtual Event Series....OCT 06, 2021 | 5:30 AM PDT
Labroots and the Cancer Research and Oncology Planning Committee are pleased to announce the 9th Annual Event in the Cancer Research & Oncology Week Virtual Event Series!...
OCT 19, 2022
| 5:30 AM PDT
Labroots announces the 2022 Coronavirus Virtual Event Series. A novel coronavirus emerged in China in 2019; it has since been dubbed COVID-19....
OCT 04, 2022
| 5:30 AM PDT
Labroots to host the 10th Annual Event in the Cancer Research & Immuno-Oncology Week Virtual Event Series! This two day event will take place on October 4-6, 2022....
APR 19, 2022
| 5:30 AM PDT
C.E. CREDITS
Labroots announces our 10th Annual Event in the Genetics Week Virtual Event Series on April 19-21, 2022! Genetics Week Virtual Event Series 2022 will offer a multi-day content-rich program....
FEB 23, 2022
| 5:30 AM PST
Labroots and the Drug Discovery planning committee are pleased to announce its 5th annual event in the Drug Discovery & Development Virtual Event Series....
OCT 06, 2021
| 5:30 AM PDT
Labroots and the Cancer Research and Oncology Planning Committee are pleased to announce the 9th Annual Event in the Cancer Research & Oncology Week Virtual Event Series!...
SEP 22, 2021
| 5:30 AM PDT
Labroots and the Cell Biology Planning Committee are pleased to announce the 5th Annual Event in the Cell Biology Virtual Event Series, providing an opportunity to...
SEP 08, 2021
| 6:00 AM PDT
Luminex's xMAP® Technology enables the evaluation of up to 500 analytes simultaneously in a single well, known as multiplexing. xMAP Technology uses color-coded microspheres as the substrate...
JUL 22, 2021
| 5:00 AM PDT
Gene and cell engineering advances have influenced almost all branches of life sciences. From the lab to the clinic, innovative gene synthesis technologies and gene editing tools have transf...
JUN 02, 2021
| 5:30 AM PDT
Labroots is pleased to announce the inauguration of the Immuno-Oncology Virtual Event Series taking place on June 2, 2021. Immuno-oncology is considered by some to be...